TopFunds

Intuitive Surgical, Inc.

NASDAQ: ISRG

Stock price

393.33 USD

(+13.76%) 5 years

Medical - Instruments & SuppliesMedical - Devices

Insider Transactions

5Y price score: 18
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +13.76%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
15-sep.-26Sale(543)374.4(203,321)1,026Widman Fredrikofficer: VP Corporate Controllerlink
11-sep.-26Sale(25)365.8(9,145)764Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
10-sep.-26Sale(23)347.7(7,996)789Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
09-sep.-26Sale(23)350.2(8,055)812Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
08-sep.-26Sale(46)361.2(16,617)835Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
21-aug.-26Sale(77)375.6(28,919)881Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
20-aug.-26Sale(77)396.4(30,520)958Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
19-aug.-26Sale(77)394.3(30,358)1,035Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
18-aug.-26Sale(77)394.0(30,338)1,112Brosius Markofficer: EVP & Chief Mfg and Supply Chalink
17-aug.-26Sale(77)390.7(30,082)1,189Brosius Markofficer: EVP & Chief Mfg and Supply Chalink

328.5

52-week range

603.8

393.33

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

2.3 %

Dividend Yield TTM

-

Market cap $

$ 138,955

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

44.7

Price / Book TTM

7.7

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

2

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

(9.8) %

13.8 %

415.8 %

Free cash flow per share growth

72 %

116.8 %

239 %

Earnings per share growth

29.8 %

167.7 %

354.9 %

Analyst ratings

Price Target Low

357.44

Price Target High

651

Price Target Median

493.5

Buy

40

Hold

12

Sell

5

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
1.7
2.1
1.9
3.2
3.9
2.9
4.7
3.7
5
6.4
7.9
16.4%
8.4
9.7
11.1
12.7
14.6
15
02FCF per share
2
2.8
2.7
2.8
3.3
3.2
4.7
2.6
2.1
3.6
6.9
13%
8.5
9.6
10.9
12.4
14.1
13.7
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
05Revenue
$ 2,384
$ 2,704
$ 3,129
$ 3,724
$ 4,479
$ 4,358
$ 5,710
$ 6,222
$ 7,124
$ 8,352
$ 10,065
15.5%
$ 11,624
$ 13,424
$ 15,503
$ 17,905
$ 20,678
$ 21,299
06ㅤ% Change
-
13.4%
15.7%
19%
20.3%
(2.7)%
31%
9%
14.5%
17.2%
20.5%
15.5%
15.5%
15.5%
15.5%
15.5%
15.5%
15.5%
07Net Income
588.8
735.9
660
1,128
1,379
1,061
1,705
1,322
1,798
2,323
2,856
17.1%
3,074
3,551
4,101
4,736
5,469
5,633
08ㅤ% Margin
24.7%
27.2%
21.1%
30.3%
30.8%
24.3%
29.9%
21.3%
25.2%
27.8%
28.4%
26.5% A
26.5%
26.5%
26.5%
26.5%
26.5%
26.5%
09CFO
771.9
1,043
1,144
1,170
1,598
1,485
2,089
1,491
1,814
2,415
3,031
14.7%
3,737
4,316
4,985
5,757
6,649
6,848
10ㅤ% Of revenue
32.4%
38.6%
36.6%
31.4%
35.7%
34.1%
36.6%
24%
25.5%
28.9%
30.1%
32.2% A
32.2%
32.2%
32.2%
32.2%
32.2%
32.2%
11CAPEX
(81)
(53.9)
(190.7)
(187.4)
(425.6)
(341.5)
(353.5)
(532.4)
(1,064)
(1,111)
(539.8)
20.9%
(652.5)
(788.8)
(953.6)
(1,153)
(1,394)
(1,685)
12ㅤ% Change
-
(33.5)%
253.8%
(1.7)%
127.1%
(19.8)%
3.5%
50.6%
99.9%
4.4%
(51.4)%
20.9% A
20.9%
20.9%
20.9%
20.9%
20.9%
20.9%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
690.9
989
953.2
982.2
1,173
1,143
1,736
958.4
749.6
1,304
2,491
13.7%
3,085
3,528
4,031
4,604
5,255
5,164
14Total assets
4,907
6,487
5,758
7,847
9,733
11,169
13,555
12,974
15,442
18,839
20,631
15.4%
23,817
27,496
31,742
36,644
42,302
48,835
15ㅤ% Change
-
32.2%
(11.2)%
36.3%
24%
14.8%
21.4%
(4.3)%
19%
22%
9.5%
15.4%
15.4%
15.4%
15.4%
15.4%
15.4%
15.4%
16Total liabilities
587.8
709.1
1,031
1,159
1,449
1,410
1,604
1,861
2,044
2,309
2,690
16.4%
3,105
3,584
4,138
4,777
5,515
6,366
17ㅤ% Of assets
12%
10.9%
17.9%
14.8%
14.9%
12.6%
11.8%
14.4%
13.2%
12.3%
13%
13% A
13%
13%
13%
13%
13%
13%
18Shareholders Equity
4,320
5,778
4,727
6,688
8,285
9,759
11,952
11,113
13,397
16,530
17,942
15.3%
20,713
23,911
27,604
31,867
36,788
42,469
19Net Debt
(3,348)
(4,838)
(3,847)
(857.9)
(1,091)
(1,623)
(1,204)
(1,581)
(2,750)
(1,881)
(3,065)
(0.9)%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
341,100
353,700
348,900
356,400
358,500
360,900
365,800
362,000
357,400
362,000
362,700
0.6%
364,934
367,181
369,443
371,718
374,008
376,311
21ㅤ% Change
-
3.7%
(1.4)%
2.2%
0.6%
0.7%
1.4%
(1)%
(1.3)%
1.3%
0.2%
0.6%
0.6%
0.6%
0.6%
0.6%
0.6%
0.6%
22ROA
12%
11.3%
11.5%
14.4%
14.2%
9.5%
12.6%
10.2%
11.6%
12.3%
13.8%
-
12.9%
12.9%
12.9%
12.9%
12.9%
11.5%
23ROE
13.6%
12.7%
14%
16.9%
16.7%
10.9%
14.3%
11.9%
13.4%
14.1%
15.9%
-
14.8%
14.9%
14.9%
14.9%
14.9%
13.3%
24Interest coverage
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
34.5
33.1
61.8
48.2
49.5
90.3
75
71.3
65.9
79.8
70.8
-
-
-
-
-
-
-
27Stock price range
51-62
56-81
70-135
125-192
150-200
123-273
228-365
183-360
225-355
322-551
430-610
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
20,261
24,288
40,765
54,453
68,219
95,718
127,947
94,385
118,481
185,400
202,134
25.9%
64,143
70,239
76,945
84,321
92,435
-
29FCF Yield
3.4%
4.1%
2.3%
1.8%
1.7%
1.2%
1.4%
1%
0.6%
0.7%
1.2%
(9.7)%
4.8%
5%
5.2%
5.5%
5.7%
-
30Average stock price
56.2
68.5
102.3
158.3
174.8
197.6
296.9
271.5
289.8
436.4
520
24.9%
175.8
191.3
208.3
226.8
247.1
-
31 CEO
DR
David J. Rosa